1. Home
  2. CLNN vs PXLW Comparison

CLNN vs PXLW Comparison

Compare CLNN & PXLW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CLNN
  • PXLW
  • Stock Information
  • Founded
  • CLNN 2012
  • PXLW 1997
  • Country
  • CLNN United States
  • PXLW United States
  • Employees
  • CLNN N/A
  • PXLW N/A
  • Industry
  • CLNN Biotechnology: Pharmaceutical Preparations
  • PXLW Semiconductors
  • Sector
  • CLNN Health Care
  • PXLW Technology
  • Exchange
  • CLNN Nasdaq
  • PXLW Nasdaq
  • Market Cap
  • CLNN 57.9M
  • PXLW 50.2M
  • IPO Year
  • CLNN N/A
  • PXLW 2000
  • Fundamental
  • Price
  • CLNN $6.17
  • PXLW $10.21
  • Analyst Decision
  • CLNN Strong Buy
  • PXLW Strong Buy
  • Analyst Count
  • CLNN 6
  • PXLW 3
  • Target Price
  • CLNN $32.67
  • PXLW $13.67
  • AVG Volume (30 Days)
  • CLNN 117.0K
  • PXLW 169.2K
  • Earning Date
  • CLNN 11-12-2025
  • PXLW 11-11-2025
  • Dividend Yield
  • CLNN N/A
  • PXLW N/A
  • EPS Growth
  • CLNN N/A
  • PXLW N/A
  • EPS
  • CLNN N/A
  • PXLW N/A
  • Revenue
  • CLNN $286,000.00
  • PXLW $33,961,000.00
  • Revenue This Year
  • CLNN N/A
  • PXLW N/A
  • Revenue Next Year
  • CLNN $2,178.18
  • PXLW $25.33
  • P/E Ratio
  • CLNN N/A
  • PXLW N/A
  • Revenue Growth
  • CLNN N/A
  • PXLW N/A
  • 52 Week Low
  • CLNN $2.28
  • PXLW $4.67
  • 52 Week High
  • CLNN $7.10
  • PXLW $15.03
  • Technical
  • Relative Strength Index (RSI)
  • CLNN 59.58
  • PXLW 52.04
  • Support Level
  • CLNN $5.77
  • PXLW $10.07
  • Resistance Level
  • CLNN $6.54
  • PXLW $13.50
  • Average True Range (ATR)
  • CLNN 0.57
  • PXLW 1.38
  • MACD
  • CLNN -0.04
  • PXLW 0.16
  • Stochastic Oscillator
  • CLNN 53.03
  • PXLW 41.77

About CLNN Clene Inc.

Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. It developed an electro-crystal-chemistry drug development platform that enables the production of concentrated, stable, clean-surfaced nanocrystal suspensions. It operates in one segment the development and commercialization of dietary supplements (Supplements). Products includes CNM-Au8, CNM-ZnA, CNM-AgZn17, rMetx, KHC46.

About PXLW Pixelworks Inc.

Pixelworks Inc is a provider of visual processing semiconductor and software solutions that enable consistently high-quality and authentic viewing experiences in a wide variety of applications. The company defines its key target markets as Mobile (smartphone and tablet), Home and Enterprise (projectors, personal video recorders (PVR), and over-the-air (OTA) streaming devices), and Cinema (creation, remastering, and delivery of digital video content). The company operates in one segment: the design, development, marketing and sale of IC solutions for use in electronic display devices. The company generates its revenue from two broad product markets: the Mobile market and the Home and Enterprise market. The majority of the revenue is earned in Japan.

Share on Social Networks: